Strathprints logo
Strathprints Home | Open Access | Browse | Search | User area | Copyright | Help | Library Home | SUPrimo

Neuropsychiatric disease and toxoplasma gondii infection

Henriquez, S.A. and Brett, Ros and Alexander, J. and Pratt, Judith and Roberts, C.W. (2009) Neuropsychiatric disease and toxoplasma gondii infection. Neuroimmunomodulation, 16 (2). pp. 122-133. ISSN 1021-7401

Full text not available in this repository. (Request a copy from the Strathclyde author)


Toxoplasma gondii infects approximately 30% of the world's population, but causes overt clinical symptoms in only a small proportion of people. In recent years, the ability of the parasite to manipulate the behaviour of infected mice and rats and alter personality attributes of humans has been reported. Furthermore, a number of studies have now suggested T. gondii infection as a risk factor for the development of schizophrenia and depression in humans. As T. gondii forms cysts that are located in various anatomical sites including the brain during a chronic infection, it is well placed anatomically to mediate these effects directly. The T. gondii genome is known to contain 2 aromatic amino acid hydroxylases that potentially could directly affect dopamine and/or serotonin biosynthesis. However, stimulation of the immune response has also recently been associated with mood and behavioural alterations in humans, and compounds designed to alter mood, such as fluoxetine, have been demonstrated to alter aspects of immune function. Herein, the evidence for T.-gondii-induced behavioural changes relevant to schizophrenia and depression is reviewed. Potential mechanisms responsible for these changes in behaviour including the role of tryptophan metabolism and the hypothalamic-pituitary-adrenal axis are discussed.

Item type: Article
ID code: 12931
Notes: Nicolle C, Manceaux L: Sur une infection à corps de Leishman (ou organismes voisins) du gondi. C R Acad Sci (Paris) 1908;147:763–766. Splendore A: Un nuovo protozoa parassita dei conigli incontrato nelle lesioni anatomiche d’una malattia che ricorda in molti punti il kalazar dell’uomo. Nota preliminario pel. Rev Soc Ciencias Sao Paulo 1908;3:109–112. Weinman D, Chandler AH: Toxoplasmosis in swine and rodents: reciprocal oral infections and potential human hazard. Proc Soc Exp Biol 1954;87:449–457. Jacobs L, Remington JS, Melton M: A survey of meat samples from swine, cattle, and sheep for the presence of encysted Toxoplasma. J Parasitol 1960;46:23–28. External Resources Hutchison WM, Dunachie JF, Siim JC, Work K: Life cycle of Toxoplasma gondii. Br Med J 1969;4:806. External Resources Frenkel JK, Dubey JP, Miller NL: Toxoplasma gondii in cats: fecal stages identified as coccidian oocysts. Science 1970;167:893–896. External Resources Janku J: Pathogenesis and pathologic anatomy of coloboma of macula lutea in eye of normal dimensions and in microphthalmic eye with parasites in retina. Casopsis Lekaru Ceskych 1923;62:1021–1027. Wolf A, Cowen D: Granulomatous encephalitomyelitis due to Encephalitozoon (encephalitozoic encephalitomylelitis): new protozoan disease of man. Bull Neurol Inst New York 1937;6:306–371. Wolf A, Cowen D, Paige D: Human toxoplasmosis: occurrence in infants as encephalitomyelitis. Verification by transmission to animals. Science 1939;89:226–227. External Resources Lyons RE, McLeod R, Roberts CW: Toxoplasmagondii tachyzoite-bradyzoite interconversion. Trends Parasitol 2002;18:198–201. External Resources Jones LA, Alexander J, Roberts CW: Ocular toxoplasmosis: in the storm of the eye. Parasite Immunol 2006;28:635–642. External Resources Hinze-Selch D, Däubener W, Eggert L, Erdag S, Stoltenberg R, Wilms S: A controlled prospective study of Toxoplasmagondii infection in individuals with schizophrenia: beyond seroprevalence. Schizophr Bull 2007;33:782–788. External Resources Torrey EF, Bartko JJ, Lun ZR, Yolken RH: Antibodies to Toxoplasmagondii in patients with schizophrenia: a meta-analysis. Schizophr Bull 2007;33:729–736. External Resources Brown AS: Prenatal infection as a risk factor for schizophrenia. Schizophr Bull 2006;32:200–202. External Resources Wang HL, Wang GH, Li QY, Shu C, Jiang MS, Guo Y: Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia. Acta Psychiatr Scand 2006;114:40–48. External Resources Mortensen PB, Nørgaard-Pedersen B, Waltoft BL, Sørensen TL, Hougaard D, Yolken RH: Early infections of Toxoplasmagondii and the later development of schizophrenia. Schizophr Bull 2007;33:741–744. External Resources Innes EA: Toxoplasmosis: comparative species susceptibility and host immune response. Comp Immunol Microbiol Infect Dis 1997;20:131–138. External Resources Alexander J, Scharton-Kersten TM, Yap G, Roberts CW, Liew FY, Sher A: Mechanisms of innate resistance to Toxoplasmagondii infection. Philos Trans R Soc Lond B Biol Sci 1997;352:1355–1359. External Resources Yap GS, Shaw MH, Ling Y, Sher A: Genetic analysis of host resistance to intracellular pathogens: lessons from studies of Toxoplasmagondii infection. Microbes Infect 2006;8:1174–1178. External Resources Debierre-Grockiego F, Campos MA, Azzouz N, Schmidt J, Bieker U, Resende MG, Mansur DS, Weingart R, Schmidt RR, Golenbock DT, Gazzinelli RT, Schwarz RT: Activation of TLR2 and TLR4 by glycosylphosphatidylinositols derived from Toxoplasmagondii. J Immunol 2007;179:1129–1137. External Resources Mun HS, Aosai F, Norose K, Piao LX, Fang H, Akira S, Yano A: Toll-like receptor 4 mediates tolerance in macrophages stimulated with Toxoplasmagondii-derived heat shock protein 70. Infect Immun 2005;73:4634–4642. External Resources Aosai F, Rodriguez Pena MS, Mun HS, Fang H, Mitsunaga T, Norose K, Kang HK, Bae YS, Yano A: Toxoplasmagondii-derived heat shock protein 70 stimulates maturation of murine bone marrow-derived dendritic cells via Toll-like receptor 4. Cell Stress Chaperones 2006;11:13–22. External Resources Lauw FN, Caffrey DR, Golenbock DT: Of mice and man: TLR11 (finally) finds profilin. Trends Immunol 2005;26:509–511. External Resources Aliberti J, Valenzuela JG, Carruthers VB, Hieny S, Andersen J, Charest H, Reise Sousa C, Fairlamb A, Ribeiro JM, Sher A: Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells. Nat Immunol 2003;4:485–490. External Resources Parker SJ, Roberts CW, Alexander J: CD8+ T cells are the major lymphocyte subpopulation involved in the protective immune response to Toxoplasma gondii in mice. Clin Exp Immunol 1991;84:207–212. External Resources Johnson JJ, Roberts CW, Pope C, Roberts F, Kirisits MJ, Estes R, Mui E, Krieger T, Brown CR, Forman J, McLeod R: In vitro correlates of Ld-restricted resistance to toxoplasmic encephalitis and their critical dependence on parasite strain. J Immunol 2002;169:966–973. External Resources Combe CL, Curiel TJ, Moretto MM, Khan IA: NK cells help to induce CD8(+)-T-cell immunity against Toxoplasmagondii in the absence of CD4(+) T cells. Infect Immun 2005;73:4913–4921. External Resources Blackwell JM, Roberts CW, Alexander J: Influence of genes within the MHC on mortality and brain cyst development in mice infected with Toxoplasmagondii: kinetics of immune regulation in BALB H-2 congenic mice. Parasite Immunol 1993;15:317–324. External Resources Brown CR, McLeod R: Class I MHC genes and CD8+ T cells determine cyst number in Toxoplasmagondii infection. J Immunol 1990;145:3438–3441. External Resources Gazzinelli RT, Oswald IP, James SL, Sher A: IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. J Immunol 1992;148:1792–1796. External Resources Gazzinelli RT, Wysocka M, Hieny S, Scharton-Kersten T, Cheever A, Kühn R, Müller W, Trinchieri G, Sher A: In the absence of endogenous IL-10, mice acutely infected with Toxoplasmagondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J Immunol 1996;157:798–805. External Resources Nickdel MB, Lyons RE, Roberts F, Brombacher F, Hunter CA, Alexander J, Roberts CW: Intestinal pathology during acute toxoplasmosis is IL-4 dependent and unrelated to parasite burden. Parasite Immunol 2004;26:75–82. External Resources Nickdel MB, Roberts F, Brombacher F, Alexander J, Roberts CW: Counter-protective role for interleukin-5 during acute Toxoplasma gondii infection. Infect Immun 2001;69:1044–1052. External Resources Villard O, Candolfi E, Despringre JL, Derouin F, Marcellin L, Viville S, Kien T: Protective effect of low doses of an anti-IL-4 monoclonal antibody in a murine model of acute toxoplasmosis. Parasite Immunol 1995;17:233–236. External Resources Roberts CW, Ferguson DJ, Jebbari H, Satoskar A, Bluethmann H, Alexander J: Different roles for interleukin-4 during the course of Toxoplasmagondii infection. Infect Immun 1996;64:897–904. External Resources Suzuki Y, Yang Q, Yang S, Nguyen N, Lim S, Liesenfeld O, Kojima T, Remington JS: IL-4 is protective against development of toxoplasmic encephalitis. J Immunol 1996;157:2564–2569. External Resources Alexander J, Jebbari H, Bluethmann H, Brombacher F, Roberts CW: The role of IL-4 in adult acquired and congenital toxoplasmosis. Int J Parasitol 1998;28:113–120. External Resources Hunter CA, Roberts CW, Alexander J: Kinetics of cytokine mRNA production in the brains of mice with progressive toxoplasmic encephalitis. Eur J Immunol 1992;22:2317–2322. External Resources Hunter CA, Roberts CW, Murray M, Alexander J: Detection of cytokine mRNA in the brains of mice with toxoplasmic encephalitis. Parasite Immunol 1992;14:405–413. External Resources Burke JM, Roberts CW, Hunter CA, Murray M, Alexander J: Temporal differences in the expression of mRNA for IL-10 and IFN-gamma in the brains and spleens of C57BL/10 mice infected with Toxoplasmagondii. Parasite Immunol 1994;16:305–314. External Resources Schlüter D, Kaefer N, Hof H, Wiestler OD, Deckert-Schlüter M: Expression pattern and cellular origin of cytokines in the normal and Toxoplasmagondii-infected murine brain. Am J Pathol 1997;150:1021–1035. External Resources Schlüter D, Kwok LY, Lütjen S, Soltek S, Hoffmann S, Körner H, Deckert M: Both lymphotoxin-alpha and TNF are crucial for control of Toxoplasmagondii in the central nervous system. J Immunol 2003;170:6172–6182. External Resources Wilson EH, Wille-Reece U, Dzierszinski F, Hunter CA: A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis. J Neuroimmunol 2005;165:63–74. External Resources Li Y, Chu N, Hu A, Gran B, Rostami A, Zhang GX: Inducible IL-23p19 expression in human microglia via p38 MAPK and NF-kappaB signal pathways. Exp Mol Pathol 2008;84:1–8. External Resources Kawanokuchi J, Shimizu K, Nitta A, Yamada K, Mizuno T, Takeuchi H, Suzumura A: Production and functions of IL-17 in microglia. J Neuroimmunol 2008;194:54–61. External Resources Dunn AJ: Effects of cytokines and infections on brain neurochemistry. Clin Neurosci Res 2006;6:52–68. External Resources Müller N, Schwarz MJ: The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view. J Neural Transm 2007;(suppl 72):269–280. External Resources Müller N, Schwarz MJ: The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol Psychiatry 2007;12:988–1000. External Resources Flegr J: Effects of toxoplasma on human behavior. Schizophr Bull 2007;33:757–760. External Resources Flegr J, Preiss M, Klose J, Havlícek J, Vitáková M, Kodym P: Decreased level of psychobiological factor novelty seeking and lower intelligence in men latently infected with the protozoan parasite Toxoplasma gondii dopamine, a missing link between schizophrenia and toxoplasmosis? Biol Psychol 2003;63:253–268. External Resources Skallová A, Novotná M, Kolbeková P, Gasová Z, Veselý V, Sechovská M, Flegr J: Decreased level of novelty seeking in blood donors infected with Toxoplasma. Neuro Endocrinol Lett 2005;26:480–486. External Resources Hodková H, Kolbeková P, Skallová A, Lindová J, Flegr J: Higher perceived dominance in Toxoplasma infected men – A new evidence for role of increased level of testosterone in toxoplasmosis-associated changes in human behavior. Neuro Endocrinol Lett 2007;28:110–114. External Resources Novotná M, Hanusova J, Klose J, Preiss M, Havlicek J, Roubalová K, Flegr J: Probable neuroimmunological link between Toxoplasma and cytomegalovirus infections and personality changes in the human host. BMC Infect Dis 2005;5:54. External Resources Flegr J, Havlícek J, Kodym P, Malý M, Smahel Z: Increased risk of traffic accidents in subjects with latent toxoplasmosis: a retrospective case-control study. BMC Infect Dis 2002;2:11. External Resources Yereli K, Balcioğlu IC, Ozbilgin A: Is Toxoplasmagondii a potential risk for traffic accidents in Turkey? Forensic Sci Int 2006;163:34–37. External Resources Delgado García G, Rodríguez Perdomo E: Reactivity of toxoplasmin intradermal test in neurotic and manic[-]depressive patients.Rev Cubana Med Trop 1980;32:35–39. Kar N, Misra B: Toxoplasma seropositivity and depression: a case report. BMC Psychiatry 2004;4:1. External Resources Hill DE, Chirukandoth S, Dubey JP: Biology and epidemiology of Toxoplasma gondii in man and animals. Anim Health Res Rev 2005;6:41–61. External Resources Berdoy M, Webster JP, Macdonald DW: Parasite-altered behaviour: is the effect of Toxoplasma gondii on Rattus norvergicus specific? Parasitology 1995;111:403–409. External Resources Berdoy M, Webster JP, Macdonald DW: Fatal attraction in Toxoplasma-infected rats: a case of parasite manipulation of its mammalian host. Proc Biol Sci 2000;267:1591–1594. External Resources Webster JP: Rats, cats, people and parasites: the impact of latent toxoplasmosis on behaviour. Microbes Infect 2001;3:1037–1045. External Resources Hay J, Hutchinson WM, Aitken PP, Graham DI: The effect of congenital and adult-acquired Toxoplasma infections on activity and responsiveness to novel stimulation on mice. Ann Trop Med Parasitol 1983;77:483–495. External Resources Hay J, Aitken PP, Hair DM, Hutchinson WM, Graham DI: The effect of congenital Toxoplasma infection on mouse activity and relative preference for exposed areas over a series of trials. Ann Trop Med Parasitol 1984;78:611–618. External Resources Hutchison WM, Aitken PP, Wells WP: Chronic Toxoplasma infections and familiarity-novelty discrimination in the mouse. Ann Trop Med Parasitol 1980;74:145–150. External Resources Hutchison WM, Aitken PP, Wells BW: Chronic Toxoplasma infections and motor performance in the mouse. Ann Trop Med Parasitol 1980;74:507–510. External Resources Hay J, Aitken PP, Graham DI: Toxoplasma infection and response to novelty in mice. Z Parasitenkd 1984;70:575–588. External Resources Webster JP, Brunton CF, Macdonald DW: Effect of Toxoplasma gondii on neophobic behaviour in wild brown rats, Rattus norvegicus. Parasitology 1994;109:37–43. External Resources Webster JP, Sequira-Gowtage S, Berdoy M, Hurd H: Predation of beetles (Tenebrio molitor) infected with tape-worms (Hymenolepis diminuta): a note of caution for the manipulation hypothesis. Parasitology 1994;121:313–319. Webster JP: The effect of Toxoplasma gondii and other parasites on activity levels in wild and hybrid Rattus norvegicus. Parasitology 1994;109:583–589. External Resources Vyas A, Kim SK, Giacomini N, Boothroyd JC, Sapolsky RM: Behavioral changes induced by Toxoplasma infection of rodents are highly specific to aversion of cat odors. Proc Natl Acad Sci USA 2007;104:6442–6447. External Resources Jones-Brando L, Torrey EF, Yolken R: Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii. Schizophr Res 2003;62:237–244. External Resources Webster JP, Lamberton PH, Donnelly CA, Torrey EF: Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stabilizer and anti-parasite medication on Toxoplasma gondii’s ability to alter host behaviour. Proc Biol Sci 2006;273:1023–1030. External Resources Ferguson DJ, Hutchison WM: The host-parasite relationship of Toxoplasma gondii in the brains of chronically infected mice. Virchows Arch A Pathol Anat Histopathol 1987;411:39–43. External Resources Stibbs HH: Changes in brain concentrations of catecholamines and indoleamines in Toxoplasma gondii infected mice. Ann Trop Med Parasitol 1985;79:153–157. External Resources Konsman JP, Parnet P, Dantzer R: Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci 2002;25:154–159. External Resources Wieczorek M, Swiergiel AH, Pournajafi-Nazarloo H, Dunn AJ: Physiological and behavioral responses to interleukin-1beta and LPS in vagotomized mice. Physiol Behav 2005;85:500–511. External Resources Tilders FJ, DeRijk RH, Van Dam AM, Vincent VA, Schotanus K, Persoons JH: Activation of the hypothalamus-pituitary-adrenal axis by bacterial endotoxins: routes and intermediate signals. Psychoneuroendocrinology 1994;19:209–232. External Resources Müller N, Schwarz MJ, Dehning S, Douhe A, Cerovecki A, Goldstein-Müller B, Spellmann I, Hetzel G, Maino K, Kleindienst N, Möller HJ, Arolt V, Riedel M: The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry 2006;11:680–684. External Resources Turnbull AV, Rivier C: Regulation of the HPA axis by cytokines. Brain Behav Immun 1995;9:253–275. External Resources Martinez FO, Sica A, Mantovani A, Locati M: Macrophage activation and polarization. Front Biosci 2008;13:453–461. External Resources Belvisi MG: Regulation of inflammatory cell function by corticosteroids. Proc Am Thorac Soc 2004;1:207–214. External Resources Gallagher P, Malik N, Newham J, Young AH, Ferrier IN, Mackin P: Antiglucocorticoid treatments for mood disorders. Cochrane Database Syst Rev 2008;1:CD005168. Türck J, Oberdörfer C, Vogel T, Mackenzie CR, Däubener W: Enhancement of antimicrobial effects by glucocorticoids. Med Microbiol Immunol 2005;194:47–53. External Resources Comings DE, Mu
Keywords: toxoplasma gondii infection, neuropsychiatric disease, biomedical sciences, Pharmacy and materia medica, Microbiology, Endocrine and Autonomic Systems, Immunology, Endocrinology, Neurology
Subjects: Medicine > Pharmacy and materia medica
Science > Microbiology
Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
Depositing user: Mr Scott Kilgariff
Date Deposited: 21 Aug 2009 15:32
Last modified: 08 Feb 2015 00:15

Actions (login required)

View Item View Item